Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

DKFZ opens postdoc role in bicyclic peptide nuclear medicine research

DKFZ is recruiting a postdoc for preclinical bicyclic peptide development in nuclear medicine, focused on PET imaging and targeted radionuclide therapy.

By Dr. Revathy Mohan V.R., MBBS · Oct 24, 2026 · 5 min read

Oncology·STAT

Pathos raises $237 million in Bristol Myers-led Series E at $3 billion valuation

Pathos raised $237 million in a Bristol Myers Squibb-led Series E, lifting its valuation to $3 billion as…

Oct 24, 2026

Oncology·STAT

Melanoma cancer vaccine cuts recurrence risk in major trial

A personalized mRNA cancer vaccine lowered melanoma recurrence risk by 42% versus standard treatment, with patients staying cancer-free…

Oct 24, 2026

Oncology·Becker P

Cencora’s $2.4B American Oncology Network deal deepens physician network strategy

Cencora is buying American Oncology Network for $2.4 billion, expanding its physician-led oncology platform and widening its reach…

Oct 24, 2026

Oncology·NIH

Precision T-cell therapy stalls treatment-resistant cancers in NIH trial

NIH reports a precision T-cell therapy slowed treatment-resistant cancers in a clinical trial, pointing to targeted cell therapy…

Oct 24, 2026

Oncology·Nature

Tumor-informed ctDNA predicts recurrence in head and neck squamous cancers

Tumor-informed ctDNA detected molecular residual disease after resection and identified recurrence risk and chemotherapy benefit in head and…

Oct 23, 2026

Oncology·BMJ

Ovarian Cancer Remote PROMs Monitoring Feasibility Trial Protocol Published

BMJ Open protocol tests remote PROMs and home measurements for ovarian cancer follow-up, aiming to reduce visit burden…

Oct 23, 2026

Oncology·Cancer Cell

Radiomics survival prediction study compares feature selection methods

A comparative radiomics study examines survival prediction and feature selection approaches in quantitative risk modeling, with implications for…

Oct 23, 2026

Oncology·bioRxiv

Glycomics Profiling Identifies Stromal Chondroitin-4-Sulfate in Ovarian Cancer

A bioRxiv preprint links stromal chondroitin-4-sulfate biology to platinum response in ovarian cancer, pointing to a new resistance…

Oct 23, 2026

Oncology·medRxiv

Cancer Trial Eligibility AI Matching Speeds Screening Across 746 Studies

A medRxiv preprint describes an AI system that converts cancer trial criteria into SQL, matching synthetic patients to…

Oct 23, 2026

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.